Company intelligence / Profile preview

Belief BioMed Inc.

Minhang, Shanghai, Chinabeliefbiomed.com ↗

Ownership: Private
Development stage: NDA

Overview

Belief BioMed has established a broad R&D pipeline with multiple gene therapy candidates targeting high unmet medical needs. The company has achieved significant progress in research and manufacturing of rAAV-based gene therapies and recently entered a strategic collaboration with AskBio to further expand its clinical reach. Specific clinical results are not detailed in public sources but the company reports "exciting results" since inception.

Therapeutic areas: HematologyRare DiseasesNeurologyRheumatology
Modalities: Gene therapy (recombinant adeno-associated virus [rAAV] vector-based therapies)
Industry: Biotech

Drug pipeline

9 assets

BBM-C101

8 more assets in the full pipeline.

Request access →

Partnerships

Asklepios BioPharmaceutical, Inc. (AskBio/Bayer AG subsidiary)

Beyond the preview

Go deeper on Belief BioMed Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Belief BioMed Inc..

Explore the full profile